Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 52 (7) , 701-707
- https://doi.org/10.1016/s0006-3223(02)01416-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- A Functional Polymorphism in the COMT Gene and Performance on a Test of Prefrontal CognitionAmerican Journal of Psychiatry, 2002
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With SchizophreniaPsychiatric Services, 2001
- MAO-A and COMT polymorphisms and gene effects in narcolepsyMolecular Psychiatry, 2001
- Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activityAmerican Journal of Medical Genetics, 1999
- Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with adhd impulsive-hyperactive phenotypeAmerican Journal of Medical Genetics, 1999
- METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-MethyltransferaseAnnual Review of Pharmacology and Toxicology, 1999
- Catechol-O-methyltransferase polymorphisms and schizophreniaPsychiatric Genetics, 1997
- The hopkins verbal learning test: Development of a new memory test with six equivalent formsThe Clinical Neuropsychologist, 1991